Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (251)
2024
-
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
Annals of Oncology, Vol. 35, Núm. 9, pp. 805-816
-
Characteristics of women with type 2 diabetes mellitus and heart failure in Spain. The DIABET-IC study
Cardiology Journal, Vol. 31, Núm. 1, pp. 103-110
-
Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy
Journal of the American Heart Association, Vol. 13, Núm. 21, pp. e036208
-
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients
Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 23-32
-
Exercise in cancer patients: assistance levels and referral pathways—a position statement from the Spanish Society of Medical Oncology
Clinical and Translational Oncology
-
Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort
Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 3, pp. 192-195
-
Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register
RMD open, Vol. 10, Núm. 1
-
Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.
Digestive and Liver Disease
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
-
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Lipids in Health and Disease , Vol. 23, Núm. 1
-
Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives
Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651
-
Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy
JACC: Clinical Electrophysiology, Vol. 10, Núm. 6, pp. 1178-1190
-
Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort—the DIABET-IC study
Cardiovascular Diabetology, Vol. 23, Núm. 1
-
Rare Genetic Variants in Young Adults Requiring Pacemaker Implantation
JACC: Clinical Electrophysiology, Vol. 10, Núm. 10, pp. 2250-2260
-
Repetitive ambulatory levosimendan as a bridge to heart transplantation
Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301
-
Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction
Circulation: Genomic and Precision Medicine, Vol. 17, Núm. 2, pp. E004404
2023
-
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients
Biomedicine and Pharmacotherapy, Vol. 159
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
-
Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2679-2691), 10.1007/s12094-023-03216-3)
Clinical and Translational Oncology
-
Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era (Bone Marrow Transplantation, (2023), 58, 6, (673-679), 10.1038/s41409-023-01949-x)
Bone Marrow Transplantation